INTRODUCTION
Pulmonary surfactant is an essential mixture containing primarily disaturated phosphatidylcholine (DSPtdCho) and key proteins that provide stability to alveoli by lowering surface-tension. Surfactant is synthesized within lung type II alveolar epithelia and packaged within lamellar bodies, an intracellular storage form of surfactant, prior to secretion into the alveolar lumen. Deficiency of surfactant DSPtdCho contributes to the pathogenesis of acute lung injury, a disorder characterized by leakage of serum proteins into the alveolus resulting in severe respiratory compromise (1) . Recent studies in our laboratory and by others suggest that cholesterol-enriched low-density lipoproteins are important components of serum that accumulate in the alveolus (2, 3) . Once becoming oxidized, these modified lipoproteins have the ability to impair DSPtdCho synthesis within alveolar type II cells (2, 3) .
Oxysterols are oxygenated derivatives of cholesterol and important constituents of oxidized low-density lipoproteins that are detected in association with surfactant during acute lung injury (4) . Oxysterols are present in human lung and exert potent biological effects by controlling expression of diverse genes via binding to liver X receptors (LXR), members of the nuclear receptor superfamily (5, 6) . As a prerequisite for nuclear transduction of oxysterol signaling, LXR receptors form heterodimers with the obligate partner, 9-cis retinoic acid receptor (RXR) , that binds to LXR/RXR response elements within target genes thereby regulating transcription (5) . However, not all regulation by oxysterols and 9-cis retinoic acid are transcriptional, as rapid activation of target proteins (e.g. kinases) has been demonstrated within minutes by these agonists via nongenomic phosphorylation reduces its activity in vitro (13, 14) . CCTα phosphorylation is restricted to sixteen serines located within the carboxyl-terminus. Seven of these Ser are followed by Pro, suggestive of a role for proline-directed kinases, such as p34 cdc2 or mitogen-activated protein (MAP) kinase, in CCTα regulation (15) . Accordingly, CCTα is an in vitro substrate
for MAP kinase and ras-transfected cells exhibit increased CCTα phosphorylation in vivo (16) (17) (18) . However, mutagenesis of consensus proline-directed phosphorylation sites or expression of a truncated CCTα mutant lacking the phosphorylation domain results in an enzyme that is phenotypically similar to wild-type CCTα, thus calling into question the physiologic role of proline-directed kinases and their link with PtdCho synthesis (19, 20) .
There is mounting data suggesting that proline-directed kinases target not only specific motifs (Ser/Thr-Pro) within substrates but efficiency and specificity of phosphorylation of the acceptor site is regulated by binding of MAP kinases to scaffolding complexes and distinct docking sites (21) . Docking domains are present within all members of the MAP kinase cascade including c-Jun N-terminal kinase (JNK), p38 kinase, and extracellular signal-regulated kinase (ERK), such as p42/p44 kinases. Many MAP kinases use a negatively charged conserved docking domain that interacts with motifs within target substrates that contain basic or hydrophobic residues; these sequences are usually located upstream of the kinase phosphorylation site (22) .
In this study we investigated the pathophysiologic role of CCTα phosphorylation within the context of oxysterol exposure in alveolar epithelia. We observed that LXR/RXR agonists greatly diminish cellular PtdCho levels by inhibiting its biosynthesis via site-specific Cell Culture-MLE cells were maintained in Hite's medium with 2% fetal bovine serum (FBS) at 37 o C in atmosphere containing 5% CO 2 . After reaching 70% confluence, the cells were harvested using 0.25% trypsin with 0.1% EDTA and plated onto either 12-well or 60 mm tissue culture dishes. After incubation overnight, the medium was replaced with serum-free Hite's medium alone (control medium) or in combination with various amounts of 22HC (5-30 µM) with or without 9-cis RA (1 µM) for up to 48 hrs. In some studies, cells were exposed to PD98059 (10µM) for 1 hr prior to addition of 22HC and 9-cis RA. Cells lysates were prepared by brief sonication in Buffer A (150 mM NaCl, 50 mM Tris, 1.0 mM EDTA, 2 mM DTT, 0.025% sodium azide, 1 mM PMSF, pH 7.4) at 4 o C.
Phosphatidylcholine (PtdCho) and Disaturated PtdCho (DSPtdCho) Analysis-Cells cultured in Hite's medium alone, or medium containing agonists for up to 48 hrs were pulsed with 2 µCi [methyl 3 H]-choline chloride during the final 2-4 hrs of incubation. Total cellular lipids were extracted from equal amounts of cellular protein using the method of . Lipids were resolved using thin layer chromatography and PtdCho or DSPtdCho quantitated using scintillation counting as described (25) . PtdCho mass was assayed by measuring lipid phosphorus content (26) .
Enzyme Activities-CCT activity was performed as described without inclusion of lipid activator in the reaction mixture (26) .
Immunoblot Analysis -Immunoblotting was performed as described (2) . In some studies, CCTα was immunoprecipitated from equal amounts of cell lysate prior to SDS-PAGE (26) .
Immunoreactive proteins were probed for using the ECL Western blotting detection system. The dilution factor for anti-CCTα, phosphorylated p42/44 MAP kinase, and cdc2 kinase antibodies was 1:1000 and for PKC 1:100. To control for loading, blots were also probed with rabbit polyclonal antibody to β-actin or total p42/44 kinase at 1:1000 dilution.
In separate studies, lysates from cells transiently transfected with pCMV5-CCTα-histidine tag plasmids were harvested using the M-PER mammalian protein extraction reagent.
CCTα-histidine tag proteins were purified using the B-PER 6Xhis spin purification kit following the manufacturer's instructions (Pierce, Rockford, IL). Levels of phosphoserine, phosphorylated p42/44 MAP kinase, PKC, cdc2 kinase, or CCTα were then determined by probing membranes with antibody at 1:1000 dilution and for PKC at 1:100.
ERK Kinase Assay-To determine assess ERK kinase activity in vivo, cells were cotransfected with pTET-Elk and pTRE-luc plasmids per the manufacturer's instructions in the presence or absence of a constitutive active MEK1 plasmid as previously shown (27, 28 reading frame (ORF) (~1100 bp) for rat CCTα was generated using PCR as described previously and ligated into a pCMV5 expression vector (pCMV5-CCTα) (2) . A C-terminal histidine-tagged full-length CCTα (pCMV5-CCTα−his) was generated by PCR using pCMV5-CCTα as a template as we described (2) . A CCTα NH 2 -terminal truncated deletion mutant (termed CCT N40 ), lacking the first 40 amino acid residues was generated as follows: pCMV5-CCTα was used as a template for PCR using the sense primer: 5'-aga tct atg tta cgg cag cca gct cc -3' and anti-sense primer: 5'-tct aga tta gtc ctc ttc atc ctc gct g-3' in a two-step PCR amplification using A series of carboxyl-terminal truncated CCTα mutants were generated as follows:
pCMV5-CCTα was used as a template for PCR using the sense primer, 5'-gga tcc ata tgg atg cac aga gtt cag c -3' and different anti-sense primers: 5'-acg cgt tta tga ctt ttc ctc cac atc -3'for CCT 260 , 5'-acg cgt tta ctc ctc cca ctt ctg gat gag-3' for CCT 280 , 5'-acg cgt tta aat gaa ctc tcg gga ctt c -3'for CCT 286 , and 5'-acg cgt tta ctt cag cgc tcc ttc tgg acc-3' for CCT 300 , respectively. The PCR products were purified using the Geneclean2 kit, cloned into pCR4-TOPO, and plasmids minipreps verified by DNA sequencing. Preparation of p38-GST Agarose-p38-GST agarose was prepared from NH 2 -terminal GST tagged full length p38 recombinant protein and GST protein-agarose. Proteins Samples were resolved by 10% SDS-PAGE, transferred to nitrocellulose membranes, and analyzed by CCTα immunoblotting and autoradiography.
For in vivo 32 P labeling, MLE cells were exposed to medium with or without agonists as described above. After 20 hrs, cells were washed twice with phosphate-free medium, and incubated in the same media with 750 µCi 32 P orthophosphate for 24 hr (13). Cells were then harvested in RIPA buffer (10 mM Na 2 HPO 4 , 100 mM NaCl, 5 mM EDTA, 5 mM EGTA, 100 mM NaF, 10 mM Na 3 VO 4 , 1 mM PMSF, 20 µM leupeptin, 1% (v/v) Triton X-100) and precleared for 2 hr at 4°C using Sepharose CL-4B, protein A and preimmune rabbit serum. Cleared supernatants (500 µl) were incubated overnight at 4°C with 1 µg of rabbit anti-CCT antibody, which was previously bound to protein A. The following morning, the immunoprecipitates were washed with lysis buffer (50 mM HEPES, 150 mM NaCl, 0.5 mM EGTA, 50 mM NaF, 10 mM Na 3 VO 4 , 1 mM PMSF, 20 uM leupeptin, 1%
(v/v) Triton X-100), and the pellets were placed in SDS protein sample buffer and heated to 95°C for 5 min. Soluble proteins were separated using 10% SDS-Page, the gels dried and subjected to autoradiography as above (2) . Alternatively, to determine CCTα phosphorylation, cells were transfected with his-tagged CCTα constructs with or without 1A and Fig.1A [inset] ). However, significant inhibitory effects on [methyl 3 H]-choline incorporation into PtdCho were also achieved with 22HC and 9-cis RA as early as 6 hrs after exposure with maximal effects seen by 48 hrs (Fig. 1A) . Increasing concentrations of oxysterol in combination with fixed amounts of 9-cis RA (1 µM) produced a dosedependent decrease in choline incorporation into PtdCho, (Fig. 1B ). Comparative analysis with other oxysterols revealed that 25OH also produced similar inhibitory effects on PtdCho synthesis ([ Fig. 1C 
RESULTS

Oxysterols
]). LXR/RXR agonists decreased PtdCho synthesis in cells by
significantly altering activities of enzymes within the CDP-choline pathway. There was no significant effect of 22HC and 9-cis RA on activity of choline kinase, the first committed enzyme of the pathway or of cholinephosphotransferase activity, the terminal enzyme involved in PtdCho synthesis (data not shown). However, after 6, 24, or 48 hrs of exposure, 22HC/9-cis RA inhibited CCT activity by approximately 30%-50% relative to control (Fig.1D) . Only modest inhibitory effects of 22HC and 9-cis RA on CCT activity were observed when these agents were used individually ( Fig. 1E-F 2B ). 22HC and 9-cis RA clearly increased intensity of a major product at ~42 kDa compared to control (Fig. 2B) . Next, cells were transfected with plasmids encoding his-tagged full-length CCTα and exposed to agonists, the transfectants then purified to remove endogenous CCTα, and lysates processed for immunoblotting using an anti-phosphoserine antibody (Fig. 2C) . As a control, we also probed for total levels of overexpressed CCTα protein (Fig 2C, [lower panel] ). After correction for quantity of total enzyme, 22HC and 9-cis RA increased levels of CCTα phosphorylation nearly 2-fold and 3-fold at 6 and 24 hrs of analysis, respectively (Fig. 2D) . In separate experiments, endogenous CCTα was immunoprecipitated and probed with an anti-phosphoserine antibody after stimulation of cells with 22HC and RA (Fig. 2D, [inset] ). Three bands exhibiting varying mobilities (~42 kDa) on autoradiograms were detected; these CCTα phosphorylation bands increased in intensity after 22HC and 9-cis RA treatment. Thus, 22HC and 9-cis RA increased phosphorylation of both endogenous and overexpressed CCTα.
Oxysterols/RA Increase CCTα Phosphorylation via a MAP kinase-We used two complementary approaches to assess p42/44 activation by 22HC and 9-cis RA. As shown by immunoblotting, 22HC and 9-cis RA exerted a biphasic temporal pattern of activation of p42/44 kinase in MLE cells as described elseware (31) (32) (33) (34) . First, the agonists increased levels of phosphorylated p42/44 MAP kinase in cells within 15 min and kinase activation was detected for up to 6 hrs (Fig. 3A) . In addition, a late-phase pattern of p42/44 MAP kinase activation was seen from 18-21 hrs after the stimulus with activity waning by 24 hrs (Fig. 3A) . As a second method, we measured p42/44 kinase activity in vivo using a luciferase reporter plasmid, driven by Elk (Fig. 3B ). In this assay, when Elk is phosphorylated by p42/44 kinase via constitutive active MEK1, phosphorylated Elk binds to a tetracycline-response element within the luciferase promoter to induce reporter expression. Cells were transiently co-transfected with the luciferase reporter plasmid, the Elk plasmid, and either an empty vector or the constitutive active MEK1. Cells exposed to 22HC and 9-cis RA exhibited a ~2-fold increase in reporter gene expression compared to control. In addition, expression of constitutively active MEK1 also produced a ~30% increase in p42/44 kinase activation in response to agonist stimulation (p<0.001, n=4, Fig.   3B ). Additional studies examining the kinetics of p42/44 kinase activation using this system demonstrated that luciferase activity was increased by 22HC and 9-cis RA uniformly from 6 to 24 hrs (Fig. 3C) . These latter studies strongly link 22HC and 9-cis RA inhibition of CCT activity with p42/44 kinase activation (Fig. 3A) as the luciferase reporter method is a functional readout that assesses activation of the transcription factor Elk, an important down-stream physiologic target for p42/44 kinase. into PtdCho (Fig. 3D-E) . In these studies, 22HC and 9-cis RA decreased CCT activity from were transfected with pCMV5-CCTα-his in the presence or absence of 22HC and 9-cis RA, CCTα was purified using a his-column, and proteins resolved using SDS-PAGE prior to immunoblotting for phosphorylated or total p42/44 kinase (Fig. 3F) . Results show that phosphorylated (active) p42/44 kinase was variably associated with CCTα protein and that this association increased at 3, 6, 21, and 24 hrs after 22HC and 9-cis RA exposure (Fig.   3F ). In contrast, nonspecific binding to the his-column was not observed either from endogenous CCTα protein or p42/44 kinase in cell lysates (Fig. 3G, [lanes 2-3] ) or after recombinant p44 kinase was applied to the column (data not shown). To further assess specificity of kinase binding to our his-columns, we first detected immunoreactive CCTα protein, p42/p44 kinase, cdc2 kinase, and PKC in MLE cells following cellular transfection with pCMV5-CCTα-his (Fig. 3H, [lysates] ). Next, CCTα was purified from cells transfected with pCMV5-CCTα-his as above. Unlike p42/p44 kinase, we did not detect cdc2 kinase or PKC in association with CCTα protein in these studies (Fig. 3H, [fraction] ).
To determine if endogenous CCTα was associated with total p42/44, we performed immunoprecipitation studies after cells were cultured in the presence or absence of agonists (Fig. 3I) . We first performed immunoprecipitation using anti-p42/44 kinase or normal rabbit IgG followed by immunoblotting with anti-CCTα antibodies. As shown in Fig.   3I (left panel), CCTα was detected with immunoprecipitated p42/44 kinase in the presence or absence of oxysterol and 9-cis RA exposure whereas this association was not detectable using control (rabbit IgG) antibody. Conversely, immunoprecipitation using
CCTα antibodies followed by immunoblotting with an antibody to total p42/44 kinase also revealed that the kinase was detected in association with CCTα (Fig. 3I, right panel) . As a negative control, this association was not observed using pre-immune serum. Thus, endogenous CCTα and total p42/p44 kinase are detected in close association as are overexpressed CCTα and the activated kinase.
Mapping of ERK Docking Sites within CCTα -MAP kinase phosphorylation of substrates involve docking interactions at motifs often very distant to phosphoacceptor sites that are essential for efficient phosphorylation. These motifs often harbor clusters of basic residues, FXFP motifs, or LXL motifs (35) . Data base analysis of the CCTα sequence uncovered similar regions suggestive of potential p42/44 kinase docking sites. Thus, we initially used a candidate approach by deleting or mutating these core regions within CCTα (Fig. 4A ).
Four mutants, CCT N40 , CCT 158 , CCT m289 , and CCT d21 were constructed where candidate sites were removed or mutated and tested for kinase binding after in vitro translation (Fig.   4 , left panels) and analyzed using an ERK pull-down assay (Fig. 4, right panels) . As shown in Figure 4 , each of these mutants were sufficiently translated ( Figs 4B, D, F) . Deletion of 40 residues from the CCTα NH 2 -terminus (CCT N40 ), 21 residues (231-251) internally (CCT d21 ), or mutations within potential docking sites at CCTα m158 failed to alter CCTα-ERK binding (Fig. 4C, E) . Moreover, a double mutant (CCT m289 ) lacking the entire membrane binding domain (residues 240-290) and harboring an NH 2 -terminal site mutation at CCTα We next tested several CCTα mutants that were progressively truncated within the membrane binding domain (at the carboxyl-terminus) to map an ERK docking site (Fig. 4F-G ). Although full-length CCTα and a CCT mutant harboring the first 300 residues effectively bound ERK, this binding was not observed in mutants that contained less than resides with a span of 14 residues localized within the membrane binding domain (CCTα 287-300) (Fig. 4E,G) . Finally, to assess binding specificity, newly synthesized full-length CCTα was incubated with either ERK GST agarose, p38 GST agarose, or GST-agarose beads alone. As shown in Fig. 4H , only ERK exhibited robust binding to CCTα.
Because the above data suggested that an ERK-CCTα docking domain is present within the membrane binding region, we further investigated if these in vitro results could (Fig. 5F ).
DISCUSSION
These results show that oxysterols in combination with their obligate partner, 9-cis RA, significantly inhibit cellular PtdCho biosynthesis by ERK-dependent phosphorylation of the regulatory enzyme, CCTα. The ERK kinase binds CCTα via a unique docking region that was mapped to an amphipathic helical region previously shown to interact with membranes (36, 37) . This docking region is upstream to a CCTα phosphoacceptor site that was functionally characterized in vivo; indeed, by expressing CCTα variants harboring truncated phosphodomains or mutations at proline-directed sites, we observed marked variations in sensitivity of cells to LXR/RXR agonists. Specifically, we show that Ser 315 was a critical site that was targeted by p42/44 kinase as mutagenesis of this site was not only required but sufficient to substantially block inhibitory effects of 22HC/9-cis RA on PtdCho synthesis. The significance of these studies is that oxysterol activation of stress kinases could significantly reduce de novo synthesis of PtdCho and alveolar secretion of surfactant phospholipid thereby accellerating pulmonary atelectasis.
Reversible phosphorylation of CCTα was the most likely mechanism whereby LXR/RXR agonists inhibited CCT activity and PtdCho synthesis. CCTα phosphorylation is linked to membrane phospholipid synthesis with cell division, but to our knowledge these studies are the first showing physiologic relevance of specific phosphoacceptor sites (18, 38, 39) . Our results mechanistically differ from inhibitory effects of 25HC on PtdCho synthesis that are dependently regulated with cholesterol biosynthesis (40, 41) . In our studies, we used 22HC, a more potent LXR ligand that in combination with 9-cis-RA did not reduce CCTα protein expression. Rather, the magnitude by which 22HC and 9-cis RA inhibited CCTα activity inversely correlated with the degree of enzyme phosphorylation (Figs. 1-2 ). Our data also indicate that p42/44 MAP kinase pathway was the primary mediator for 22HC and 9-cis RA signaling as i) the kinetics of p42/44 kinase activation by 22HC and 9-cis RA coincided with CCTα docking, phosphorylation, and inhibition of enzyme activity, ii) CCTα and p42/44 kinase were physically associated in vivo, iii) p42/p44 MAP kinase phosphorylated CCTα, and iv) effects of these agents on PtdCho synthesis were reversed using PD98059 and a dominant-negative p42 kinase (Fig. 3) . In particular, we observed a fairly tight correlation between p42/44 kinase activation and inhibition of CCT activity by 22HC and 9-cis RA. The biphasic activation of MAP kinases (up to 6 hrs and at 18-21 hrs) in response to 22HC and 9-cis RA was temporally linked to inhibition of PtdCho synthesis at 6 and 24 hrs by these agents (Figs.1, 3A) . Even though total cellular phosphorylated p42/44 kinase activity dissipated by 24 hrs, a distinct pool of active kinase was still bound to CCTα after 22HC and 9-cis RA exposure (Fig. 3F) ; this together with the extended half-life of CCTα protein (26) provides a plausible explanation for reduced levels of CCT activity and PtdCho synthesis observed at 24 hrs following agonist treatment (Fig. 1) . Further, this pattern is highly consistent with the kinetics of ERK kinases as they regulate a variety of physiologic readouts such as platelet derived growth factor-induced mitogenesis (31), cellular propagation of influenza (32), leukotactin-1 control of cell cycle progression (33) , and effects of phorbol-esters and nerve growth factors on cell survival (34, 42) . Although the data favor 22HC and 9-cis RA activation of p42/44 kinase, concurrent activation of p38 kinase, JNK, or p34 cdc2 kinase is also possible as these enzymes utilize similar minimal recognition motifs ((Ser/Thr) Pro) for substrate phosphorylation (43, 44) . On the other hand, because (Ser/Thr) Pro sequences are fairly ubiquitous within substrates, specificity and prevention of inappropriate cross-talk between related kinases is provided by assembly of scaffolding proteins and interaction with docking regions on target proteins (45).
We localized an ERK docking region to the distal membrane binding region of CCTα.
This motif (GSFLEMFGPEGALK) is rich in nonpolar residues that helps form a putative amphipathic α-helix, helix-1, for membrane insertion and lipid activation (36) . This interaction resembles that of p44 kinase docking with PDE4 cAMP phosphodiesterase where a docking site is also located on an exposed α-helix (46) . Results of deletional analysis using truncated mutants of helix-1 showed that residues 287-300 were required for p42/44 kinase-CCTα binding, and that this domain was also required for optimal phosphorylation of the enzyme. Our studies do not rule out the possibility that the putative docking region within CCTα might involve a broader motif encompassing the entire α-helix or that other residues (e.g. 260 to 286) might optimize ERK-CCTα binding. This dock sequence is enriched with hydrophobic residues typical of many dock sites, but it has few basic residues and lacks LXL or FXF motifs commonly seen in some substrates (35, (47) (48) (49) Reaction products were purified, resolved using SDS-PAGE and processed for autoradiography to detect levels of γ-32 P -labeled CCTα. In the middle and lower rows, lysates were processed for immunoblotting and probed with either a polyclonal antibody to phosphorylated p42/44 kinase (middle) or to CCTα (lower). Cells were transfected with plasmids encoding wild-type CCTα, or one of two full-length mutants (CCTα quad , and CCTα 315 ) harboring mutations within the carboxyl-terminus. Cells were subsequently exposed to medium with or without 22HC with 9-cis RA and processed for
